As a consequence, the combination of two or more polymorphisms in different UGT1A isoforms may be a more accurate indicator for the occurrence of UGT1A SNP-associated liver protection during NAFLD or NASH in human population studies. The gene discussed is UGT1A1; the disease is metabolic dysfunction-associated steatotic liver disease.